Daily Morning Note – 9 February 2022

Welcome to our Daily Morning Note from our Research team!


Stocks in Asia may get a boost Wednesday after broad-based gains on Wall Street on expectations economic growth will withstand higher interest rates. Treasuries extended declines. Futures rose in Japan, Australia and Hong Kong. The S&P 500 closed near session highs amid gains in financials and materials sectors. Dip-buying in some big tech names like Apple Inc. and Microsoft Corp. helped lift the Nasdaq 100. The Russell 2000 of small-caps outperformed. The 10-year Treasury yield climbed toward levels last seen in 2019 as the Federal Reserve gears up to raise rates to combat inflation. The dollar edged higher against a basket of peers. China’s stocks will be in focus. Chinese state-backed funds intervened in the stock market on Tuesday, helping the benchmark index stage a strong recovery from its biggest intraday drop since August 2021. The Nasdaq Golden Dragon China Index jumped the most in a week.

Top gainers & losers




The revised scheme consideration for ESR Reit’s offer for ARA Logos Logistics Trust (ALog) was determined by various factors such as the merger’s commercial appeal, the quality of ALog’s portfolio and the strong conviction that a merger is the best way forward for both, ALog’s manager has said. In a filing to the Singapore Exchange which highlighted the manager’s response to unitholders’ frequently asked questions, ALog’s manager emphasised that the “proposed transaction is intended as a merger and not a complete sell-out of ALog and/or its underlying assets”.

Mermaid Maritime’s subsidiary, Mermaid Subsea Services (International) (MSSI), has entered into a two year charter-in contract for a DP2 diving support construction vessel (DSCV), of which it has already taken delivery. In a filing to the Singapore Exchange on Tuesday, Mermaid Maritime said MSSI will deploy the DSCV Van Gogh to support its various subsea projects, starting this month. The contract also comes with two one-year extension options, which, if exercised, would extend the charter period through to February 2026.

ComfortDelGro’s flag-down fares will rise by 20 Singapore cents across its entire fleet from Mar 1, bringing the rates to between S$3.90 and S$4.10 from its current range of S$3.70 to S$3.90. Meanwhile, metered charges will increase by 2 cents to S$0.24 for normal taxis and 3 cents to S$0.33 for limousine taxis. All other fare tariffs will remain unchanged. As a result, the company estimates that a 10 km off-peak normal taxi trip, for example, will increase by 7.7 per cent or S$0.84 to S$11.82 from S$10.98.

The manager of Ascendas Reit is planning to deepen its presence in the US and Europe markets as the real estate investment trust (Reit) continues to seek growth. But chief executive of the Reit manager William Tay believes it is “tough” to exceed the pace of acquisitions completed in FY2021. Ascendas Reit completed S$2.12 billion worth of acquisitions and developments in FY2021, including the purchase of 11 data centres in Europe and 11 logistics properties in the US.

Chinese property developer Yanlord Land Group logged 9.81 billion yuan (S$2.07 billion) in total contracted pre-sales from residential and commercial units, as well as car parks in January 2022, up 87.7 per cent from the 5.22 billion yuan it recorded a year ago. The pre-sales were for a contracted gross floor area (GFA) of 170,486 square metres, a 6.7 per cent increase from January 2021, according to the group’s unaudited key operating figures filed on Tuesday (Feb 8).


Thomson Reuters on Tuesday ( Feb 8) reported higher revenue in the fourth quarter and raised its dividend and sales forecast, but said operating profit was down from a year ago, when it saw a significant gain from an investment sale and other items. The news and data provider and parent company of Reuters News said fourth-quarter operating profit fell 73 per cent year on year to US$257 million. Adjusted earnings per share, which exclude one-time items, fell to 43 US cents per share from 54 US cents.

Pfizer’s forecast for full-year sales of its Covid-19 vaccine and antiviral pill fell short of lofty Wall Street estimates on Tuesday, sending the drugmaker’s shares down 4 per cent before the bell. Pfizer said it expects to post US$54 billion in combined sales of both the products this year, with Covid-19 vaccine sales coming in at US$32 billion and sales from Paxlovid, its oral antiviral to treat the disease, at US$22 billion.

The US Commerce Department said on Monday it had added 33 Chinese entities to its so-called ‘unverified list’, which requires US exporters to go through more procedures before shipping goods to the entities. WuXi Biologics saw its stock plummet more than 25 per cent on Tuesday to wipe US$9.9 billion off its market value following the addition of its units in Wuxi and Shanghai to the list. Trade in its shares was later halted.

Boeing said on Tuesday (Feb 8) it delivered 32 aircraft in January, the lowest in three months, as its sidelined 787 Dreamliner programme continued to weigh on the planemaker’s ability to capitalise on a recovery in air travel. The company handed over 27 737 MAX jets in January and three widebody aircraft, including a 777 freighter, Boeing said in its closely watched monthly report.

Source: SGX Masnet, The Business Times, Bloomberg, Channel NewsAsia, Reuters, CNBC, PSR

Singapore Banking Monthly – Interest rates down in January

Recommendation: Overweight (Maintained)

Analyst: Glenn Thum

• January’s 3M-SOR down MoM, 3M-SIBOR remains flat.

• Hong Kong’s domestic loans growth increased 3.79% YoY in December. Malaysia’s domestic loans growth increased 4.51% YoY and rose 0.53% MoM in December.

• Our 4Q21e PATMI estimates are: DBS (S$1.4bn), UOB (S$1.3bn) and OCBC (S$1.1bn). Valuations for OCBC are the most attractive and largest upside surprise from dividends.

• Maintain OVERWEIGHT. We remain positive on banks. Bank dividend yields are attractive with upside surprise due to excess capital ratios. Improving economic conditions and rising interest rates remain tailwinds for the banking sector. SGX is another beneficiary of higher interest rates.

Amazon.com Inc – Normalising sales growth

Recommendation: BUY (Maintained); TP US$4,079.00, Last close: US$3,228.27;
Analyst: Timothy Ang

• FY21 results were in line with revenue and PATMI at 99% and 102% of our FY21 forecasts respectively, excluding a pre-tax valuation gain of US$11.8bn from the initial public offering (IPO) of Rivian.

• Amazon Web Services (AWS) 4Q21 revenue growth accelerated to 40% YoY, above consensus of 35% and our FY21 forecast of 33%. AWS is Amazon’s key growth driver, contributing 75% of FY21 operating income.

• New Amazon Prime membership price increases of 17% in 1Q22 should largely translate to bottom line and add about 10% to FY22e profit before taxes.

• The challenge from the tight US labour market is easing. However, guidance for net sales for 1Q22 was 3-6% weaker than consensus, signalling moderating demand. Amazon’s fulfilment network is no longer running at 100% capacity. As a result, we cut FY22e revenue by 3% and reduce operating margins from 8% to 6% due to still elevated wage and fulfilment costs, which lowers our FY22e PATMI by 31%. The swing factor is in margins from easing supply constraints. Maintain BUY with a lower target price of US$4079.00 based on DCF with a WACC of 6.2% and terminal growth of 5.0%.

POEMS Podcast: Let the Money Talk

Recent Podcasts:

Keppel Corporation FY21 Results – SGX Company Insights Ep 50

Daily Morning Note – February 4, 2022

Microsoft Corporation 2Q22 Results – SGX Company Insights Ep 49

Visit www.stocksbnb.com to learn more!

Join our Phillip Securities Research Telegram channel for the latest update on our stock coverage!

Click here to join: https://t.me/stocksbnb

Webinar Of The Week

Weekly Market Outlook: Alphabet Inc, Meta Platforms Inc, CICT, Lendlease REIT, SG Weekly

Date: 7 February 2022

For more on Market Outlook

Updates summarised in 3 minutes

Phillip Research in 3 minutes: #29
Keppel Corporation; Initiation

For more videos on Phillip in 3 Mins

Read the research report(s), available through the link(s) above, for complete information including important disclosures Important Information

The information contained in this email and/or its attachment(s) is provided to you for information only and is not intended to or nor will it create/induce the creation of any binding legal relations. The information or opinions provided in this email do not constitute an investment advice, an offer or solicitation to subscribe for, purchase or sell the e investment product(s) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of this information. Investments are subject to investment risks including possible loss of the principal amount invested. The value of the product and the income from them may fall as well as rise. You may wish to seek advice from an independent financial adviser before making a commitment to purchase or investing in the investment product(s) mentioned herein. In the event that you choose not to do so, you should consider whether the investment product(s) mentioned herein is suitable for you. PhillipCapital and any of its members will not, in any event, be liable to you for any direct/indirect or any other damages of any kind arising from or in connection with your reliance on any information in and/or materials attached to this email. The information and/or materials provided 揳s is?without warranty of any kind, either express or implied. In particular, no warranty regarding accuracy or fitness for a purpose is given in connection with such information and materials.
Confidentiality Note
This e-mail and its attachment(s) may contain privileged or confidential information, which is intended only for the use of the recipient(s) named above. If you have received this message in error, please notify the sender immediately and delete all copies of it. If you are not the intended recipient, you must not read, use, copy, store, disseminate and/or disclose to any person this email and any of its attachment(s). PhillipCapital and its members will not accept legal responsibility for the contents of this message. Thank you for your cooperation.


Contact us to Open an Account

Need Assistance? Share your Details and we’ll get back to you


This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  


Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com